About Dapaglifozin IP
Discover the astounding Dapagliflozin IP, renowned for its pristine purity (>99%) and compliance with IP standards. This featured SGLT2 inhibitor has won favorable reviews for its role as a heroic anti-diabetic API, with related substances kept under 0.2% and residual solvents aligning with ICH limits. Boasting a specific rotation between +38 and +44 in methanol, this white to off-white powder delivers exceptional assay results and assured safety. Grab Yours now from India's trusted supplier and experience a product that is meticulously tested, odorless, and non-poisonous.
Plant Application, Usage and Commercial Impact of Dapagliflozin IP
Dapagliflozin IP is designed for integration into pharmaceutical manufacturing plants, specifically for developing anti-diabetic medications within the SGLT2 inhibitor category. Its precise formulation ensures optimal application in creating oral tablets for treating type 2 diabetes. Commercially, it is favored by formulators and pharmaceutical companies seeking reliable, high-quality API inputs due to its consistent assay and minimized impurities, supporting large-scale medicine production in compliance with Indian Pharmacopoeia standards.
FOB Port, Packaging, Rate, and Certification Details for Dapagliflozin IP
Dapagliflozin IP is offered at competitive rates based on current market valuation, with prompt drop-off arrangements at principal Indian FOB ports. It is securely packed in moisture-resistant, well-closed containers to ensure integrity during transit. The bulk packaging details and labeling comply with regulatory demands. Each shipment is accompanied by robust certification, including certificates of analysis and compliance with the Indian Pharmacopoeia, guaranteeing buyers a product of proven purity and stability throughout the shelf life.
FAQ's of Dapaglifozin IP:
Q: How is Dapagliflozin IP typically used in pharmaceutical applications?
A: Dapagliflozin IP serves as an active pharmaceutical ingredient (API) in the production of anti-diabetic medications, specifically for the SGLT2 inhibitor class, commonly formulated into oral tablets for controlling blood glucose in type 2 diabetes.
Q: What quality certifications are provided with Dapagliflozin IP shipments?
A: Each shipment of Dapagliflozin IP includes certifications like a Certificate of Analysis and documentation confirming compliance with the Indian Pharmacopoeia (IP) and ICH guidelines for purity, residual solvents, and microbial limits.
Q: Where is Dapagliflozin IP shipped from, and how is it packaged for export?
A: Dapagliflozin IP is shipped from major Indian FOB ports. It is packaged in well-sealed, moisture-protected containers tailored for bulk or custom quantities, ensuring product integrity throughout global transit.
Q: What are the benefits of selecting this supplier for Dapagliflozin IP?
A: Choosing this supplier offers the assurance of pristine, high-purity Dapagliflozin IP, favorable reviews from industry clients, and robust documentation. Reliability in drop-off, prompt communication, and adherence to global quality standards enhance buyer confidence.
Q: How do you verify the purity and identity of Dapagliflozin IP?
A: Purity and identification are confirmed through advanced HPLC analysis, IR spectroscopy, and specific rotation testing in methanol, ensuring compliance with regulatory benchmarks and the Indian Pharmacopoeia.